AstraZeneca | Cafepharma
Feb 20, 2026 · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. The deal covers eight …
AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …
Aug 1, 2022 · Anonymous board for AstraZeneca. We’re running a short, anonymous survey to better understand how pharma reps (and others in the industry) are actually using AI today, what concerns …
AstraZeneca | Cafepharma
4 days ago · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. The deal covers eight …
January 26 2026 - Biopharma layoffs surged last year, but 2026 is a ...
Jan 26, 2026 · Signs of renewed momentum are emerging across the sector, as companies balance the legacy of layoffs and restructuring with clinical progress, IPO hopes, and growing use of …
January 14 2026 - JPM26: AstraZeneca's $80B revenue target 'very …
Jan 14, 2026 · Confidence is on full display at JPM, as companies talk up revenue targets, pipeline momentum, and dealmaking strength—tempered by ongoing regulatory and pricing realities.JPM26: …
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales
Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
4 days ago · Cafepharma Today March 6 2026 - FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, Truqap Today’s news highlights the industry’s shifting …
AstraZeneca joins the DTC platform pack, offering up to 70% discounts ...
Sep 26, 2025 · AstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. AstraZeneca Direct will go …
AstraZeneca keeps UK research site on pause, but options open
Jan 26, 2026 · AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U.K. hometown, despite keeping its options open.
AstraZeneca sets sights on 25+ blockbusters by 2030 to fuel $80B ...
Feb 10, 2026 · After ending 2025 with a strong fourth quarter, AstraZeneca management has doubled down on its ambitious “$80 billion by 2030” revenue target, outlining a roadmap to have more than 25 …